Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Diagnosis and Management of Hyperhidrosis
BMJ 347:f6800, Benson, R.A.,et al, 2013
Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Botulinum Toxin A For Axillary Hyperhidrosis (Excessive Sweating)
NEJM 344:488-493, Heckmann,M.,et al, 2001
Botulinum Toxin Type A in Primary Palmar Hyperhidrosis
Neurol 57:2095-2099, Saadia,D.,et al, 2001
Hemifacial Spasm:Clinical Findings and Treatment
Muscle & Nerve 21:1740-1747, Wang,A & Jankovic,J, 1998
Infant Botulism:A Review of 12 Years'Experience at the Children; s Hosp of Phila
Pediatrics 87:159-165, Schreiner,M.S.,et al, 1991